| Literature DB >> 22442656 |
Alexander C Engberts, Wilco C H Jacobs, Sanne J A M Castelijns, Rene M Castelein, Carmen L A Vleggeert-Lankamp.
Abstract
PURPOSE: Thoracolumbar kyphosis (TLK) is described as a common presentation in children with achondroplasia. However, the prevalence and development of TLK are ill-defined, as well as its clinical implications. The goal of this study was to assess the existing evidence on the prevalence and development of TLK from the literature.Entities:
Keywords: Achondroplasia; Developmental bone diseases; Kyphosis; Systematic literature review
Year: 2011 PMID: 22442656 PMCID: PMC3303017 DOI: 10.1007/s11832-011-0378-7
Source DB: PubMed Journal: J Child Orthop ISSN: 1863-2521 Impact factor: 1.548
Newcastle–Ottawa Scale for the assessment of methodological quality
| Category | Item | Explanation | Scoring | Star items |
|---|---|---|---|---|
| Selection | 1) Representativeness | Is the study population representative for the average achondroplast in the community? | A) Truly representative | * |
| B) Somewhat representative | * | |||
| C) Selected group | ||||
| D) No description | ||||
| 2) Controls | Are the subjects of the non-exposed control group from the same community as the exposed group? | A) From the same community | * | |
| B) From a different source | ||||
| C) No description | ||||
| D) No control group | ||||
| 3) Ascertainment of exposure | What methods were used to determine TLK? | A) Secure record | * | |
| B) Structured interview | * | |||
| C) Written self-report | ||||
| D) No description | ||||
| 4) Baseline | Is there a baseline measurement of TLK? Demonstration of to what extent TLK was present at start of the study | A) Yes | * | |
| B) No | ||||
| Comparability | 1) Comparability | Study controls for TLK? | A) Yes | * |
| B) No | ||||
| C) No control group | ||||
| Outcome | 1) Assessment of TLK | How was TLK assessed? | A) Blind assessment | * |
| B) Record linkage | * | |||
| C) Self-report | ||||
| D) No description | ||||
| 2) Follow-up | The development of TLK over a longer period, i.e., from birth, early childhood to adolescence, and mature bone | A) Yes | * | |
| B) No | ||||
| 3) Attrition | Adequate follow-up | A) Complete follow-up | * | |
| B) Less than 20% lost | * | |||
| C) More than 20% lost | ||||
| D) No statement |
Characteristics of the included studies
| Article |
| Patient population | TLK prevalence | TLK criterium | Average TLK (°) | Distribution by age | Average age (years) |
|---|---|---|---|---|---|---|---|
| Sciubba et al. [ | 44 | Preoperative pediatric patients undergoing spinal decompressive procedures | 50% (22) | Unknown | Unknown | Unknown | 12.7 (range 5–21) |
| Schkrohowsky et al. [ | 44 | 22 with spinal stenosis (SS), 22 without SS | 100% (44) | Unknown | With SS: 24.2 (range 11.7–36.7) Without SS: 14.1 (range 4.5–23.7) | Unknown | With SS: 11.1 (range 6.9–15.3) Without SS: 11.5 (range 7.7–15.3) |
| Ain et al. [ | 10 | Laminectomy patients | 100% (10) | Unknown | Preoperative: 63 (range 46–101) Postoperative: 94 (range 78–135) | Unknown | 9.2 (range 6–16) |
| Savini et al. [ | 8 | Surgery patients, kind of surgery not specified | 100% (8) | Unknown | 56 (range 18–89) | Unknown | 37 (range 8–55) |
| Kahanovitz et al. [ | 36 | Hospital database | 50% (18) | Unknown | 38 (range 14–110) | Unknown | 15 and older |
| Bethem et al. [ | 30 | Hospital database | 60% (18) | Unknown | <50–132 (no average mentioned) | <4 years: 50% >4 years: 50% | 0–60 (no average mentioned) |
| Kopits [ | 197 | Unknown | 53% (104) | Unknown | Unknown | <1 years: 94% 1–2 years: 87% 2–5 years: 39% 5–10 years: 11% 10–15 years: 20% 20–50 years: 35% | 8.7 (range 1 month–76 years) |
Results of the quality assessment for the included studies
| Sciubba et al. [ | Schkrohowsky et al. [ | Ain et al. [ | Savini et al. [ | Kahanovitz et al. [ | Bethem et al. [ | Kopits [ | |
|---|---|---|---|---|---|---|---|
| Selection | |||||||
| Representativeness | C | C | C | C | B (*) | B (*) | D |
| Selection of non-exposed cohort | D | D | D | D | D | A (*) | A (*) |
| Ascertainment of exposure | D | A (*) | A (*) | D | D | D | D |
| Baseline measurement | A (*) | A (*) | A (*) | A (*) | B | B | B |
| Comparability | |||||||
| Comparability | C | C | C | C | C | A (*) | C |
| Outcome | |||||||
| Assessment of outcome | D | D | A (*) | D | D | D | D |
| Follow-up | B | B | B | A (*) | B | A (*) | B |
| Follow-up adequacy | A (*) | A (*) | A (*) | A (*) | C | C | D |